43598-627Level 3
Phentermine and Topiramate Extended-Release (Phentermine and Topiramate Extended-Release)
**Product type:** Human Prescription Drug
**Active ingredient:** PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
**Strength:** 15; 92 mg/1; mg/1
**Dosage form:** Capsule
**Route:** Oral
**Labeler:** Dr.Reddys Laboratories Inc
**Marketing category:** ANDA (ANDA208175)
**Pharmacologic class:** Appetite Suppression [PE], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]
**DEA schedule:** CIV
GET
/api/v1/systems/ndc_fda/nodes/43598-627Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.